142 related articles for article (PubMed ID: 7602786)
21. Two types of phosphofructokinase-1 differentially regulate the glycolytic pathway in insulin-stimulated chicken skeletal muscle.
Seki Y; Sato K; Kono T; Akiba Y
Comp Biochem Physiol B Biochem Mol Biol; 2006 Mar; 143(3):344-50. PubMed ID: 16413217
[TBL] [Abstract][Full Text] [Related]
22. Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21.
Annerén KG; Korenberg JR; Epstein CJ
Hum Genet; 1987 May; 76(1):63-5. PubMed ID: 2952576
[TBL] [Abstract][Full Text] [Related]
23. Skeletal muscle glycolytic capacity and phosphofructokinase regulation in horses with polysaccharide storage myopathy.
Valberg SJ; Townsend D; Mickelson JR
Am J Vet Res; 1998 Jun; 59(6):782-5. PubMed ID: 9622752
[TBL] [Abstract][Full Text] [Related]
24. Erythrocyte isozymes of phosphofructokinase in genetically high- and low-2,3-diphosphoglycerate rats.
Noble NA; Kuwashima LH; Togioka TT; Tanaka KR
Biochem Genet; 1982 Dec; 20(11-12):1055-65. PubMed ID: 6219662
[TBL] [Abstract][Full Text] [Related]
25. The primary structure of human liver type phosphofructokinase and its comparison with other types of PFK.
Levanon D; Danciger E; Dafni N; Bernstein Y; Elson A; Moens W; Brandeis M; Groner Y
DNA; 1989 Dec; 8(10):733-43. PubMed ID: 2533063
[TBL] [Abstract][Full Text] [Related]
26. Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.
Vora S; Seaman C; Durham S; Piomelli S
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):62-6. PubMed ID: 6444721
[TBL] [Abstract][Full Text] [Related]
27. Isozymes of phosphofructokinase.
Vora S
Isozymes Curr Top Biol Med Res; 1982; 6():119-67. PubMed ID: 6219967
[No Abstract] [Full Text] [Related]
28. Targeting of the catalytic subunit of protein phosphatase-1 to the glycolytic enzyme phosphofructokinase.
Zhao S; Lee EY
Biochemistry; 1997 Jul; 36(27):8318-24. PubMed ID: 9204878
[TBL] [Abstract][Full Text] [Related]
29. Developmental changes in heart and muscle phosphofructokinase isozymes.
Thrasher JR; Cooper MD; Dunaway GA
J Biol Chem; 1981 Aug; 256(15):7844-8. PubMed ID: 6455419
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of canine muscle type phosphofructokinase deficiency.
Smith BF; Stedman H; Rajpurohit Y; Henthorn PS; Wolfe JH; Patterson DF; Giger U
J Biol Chem; 1996 Aug; 271(33):20070-4. PubMed ID: 8702726
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of human platelet phosphofructokinase-1 locked in an activated conformation.
Kloos M; Brüser A; Kirchberger J; Schöneberg T; Sträter N
Biochem J; 2015 Aug; 469(3):421-32. PubMed ID: 26205495
[TBL] [Abstract][Full Text] [Related]
32. Structure and allosteric regulation of eukaryotic 6-phosphofructokinases.
Schöneberg T; Kloos M; Brüser A; Kirchberger J; Sträter N
Biol Chem; 2013 Aug; 394(8):977-93. PubMed ID: 23729568
[TBL] [Abstract][Full Text] [Related]
33. Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat.
Oskam R; Rijksen G; Staal GE; Vora S
Cancer Res; 1985 Jan; 45(1):135-42. PubMed ID: 3155492
[TBL] [Abstract][Full Text] [Related]
34. Postnatal hematologic development in phosphofructokinase-deficient dogs.
Harvey JW; Reddy GR
Blood; 1989 Nov; 74(7):2556-61. PubMed ID: 2529931
[TBL] [Abstract][Full Text] [Related]
35. A review of animal phosphofructokinase isozymes with an emphasis on their physiological role.
Dunaway GA
Mol Cell Biochem; 1983; 52(1):75-91. PubMed ID: 6306441
[TBL] [Abstract][Full Text] [Related]
36. Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease).
Raben N; Sherman JB; Adams E; Nakajima H; Argov Z; Plotz P
Muscle Nerve Suppl; 1995; 3():S35-8. PubMed ID: 7603525
[TBL] [Abstract][Full Text] [Related]
37. Phosphofructokinase-1 subunit composition and activity in the skeletal muscle, liver, and brain of dogs.
Kanai S; Shimada T; Narita T; Okabayashi K
J Vet Med Sci; 2019 May; 81(5):712-716. PubMed ID: 30918224
[TBL] [Abstract][Full Text] [Related]
38. Early post-mortem AMP-activated protein kinase (AMPK) activation leads to phosphofructokinase-2 and -1 (PFK-2 and PFK-1) phosphorylation and the development of pale, soft, and exudative (PSE) conditions in porcine longissimus muscle.
Shen QW; Means WJ; Underwood KR; Thompson SA; Zhu MJ; McCormick RJ; Ford SP; Ellis M; Du M
J Agric Food Chem; 2006 Jul; 54(15):5583-9. PubMed ID: 16848549
[TBL] [Abstract][Full Text] [Related]
39. Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation.
Sivakumar K; Vasconcelos O; Goldfarb L; Dalakas MC
Neurology; 1996 May; 46(5):1337-42. PubMed ID: 8628478
[TBL] [Abstract][Full Text] [Related]
40. Production and characterization of monoclonal antibodies to the subunits of human phosphofructokinase: new tools for the immunochemical and genetic analyses of isozymes.
Vora S; Wims LA; Durham S; Morrison SL
Blood; 1981 Oct; 58(4):823-9. PubMed ID: 6456026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
